Pick the Right Pathway: How 505(b)(2) Beats the Branded Generic Every Time — Unless It Doesn’t
In the high-stakes world of pharmaceutical innovation, choosing the right pathway isn’t just a strategic decision—it’s a game-changer that can make or break a company’s success. Yet, many companies find themselves caught in a complex maze of regulatory…
